Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quaker/Rhodia

This article was originally published in The Tan Sheet

Executive Summary

Citizen petition from joint-venture requesting agency expand soluble fiber/coronary heart disease health claim officially filed with FDA July 20. Petition would have health claim additionally pertain to 3 g per day or .75 g/serving Oatrim (BetaTrim), a combination of "oat beta-glucan soluble fiber and oat starch." Quaker/Rhodia state levels of Oatrim included in their petition would help "make a significant impact on serum lipid levels." Although BetaTrim currently is used in foods, a trademark using the name that referred to "dietary and nutritional supplements" was issued July 17. FDA approved the original fiber/CHD health claim about four years ago

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel